Elie Haddad MD, PhD

Dr. Elie Haddad specializes in clinical and basic research in pediatric immunology. After completing his medical training in pediatric immunology and hematopoietic stem cell transplantation with Dr. Alain Fischer in Paris, he obtained his Ph.D. in fundamental immunology (Villejuif, France) and then undertook postdoctoral work in immunonephrology at Hôpital Bichat. He was recruited by CHU Sainte-Justine as a physician-scientist and the head of the Immuno-Allergy and Rheumatology Division. Dr. Haddad is a Professor of Pediatrics at the University of Montreal, Canada, and he is the Head of the Research Axis “Immune Diseases and Cancer” at CHU Sainte-Justine Research Centre.

Dr. Elie Haddad's major activity of clinical research is focused on primary immune deficiency and as a recognized international expert in this field, he is an elected councilor of the Clinical Immunology Society (CIS). He is one of the three PI of the Primary Immune Deficiency Treatment Consortium, an NIH-funded consortium of 47 North-American Centers. He is also one of the Faculty of the CIS summer school. The major activity of his fundamental research is on cancer immunotherapy, mostly in the field of NK-cell and stem-cell-based cellular therapy. Dr. Haddad has also set up a humanized mice platform to develop relevant and innovative preclinical models of cancer immunotherapy and the study of immunopathology.